Our Mission
SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (augumented intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Early detection at point of care
Nevisense
The Nevisense platform uses advanced technology powered by AI (augumented intelligence) to empower healthcare professionals by facilitating improved diagnostic accuracy, enabled disease monitoring, and early detection of melanoma at the most curable stage. Its a non-invasive measurement that provides phycisians with objective and actionable data at point-of-care.
News
Events
SciBase partner with a large health care group in Los Angeles, Unified Health, and receives a first order
June 28, 2024STOCKHOLM, SVERIGE, 28 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase], a leading developer of augmented intelligence-based solutions for skin disorders announced today that it continues to expand in California with a collaboration agreement with Unified Health. Unified Health has nine clinics in Southern California.
SciBase welcomes new chairman and thanks the former
June 13, 2024STOCKHOLM, SVERIGE, 13 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase, a leading developer of AI-based solutions for skin diseases, today announces the election of Jesper Høiland as the new Chairman of the Board.
SciBase strengthens the US organization with experienced leader in dermatology
STOCKHOLM, SVERIGE, 13 June 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], SciBase, a leading developer of AI-based solutions for skin diseases, today announces that Leda Beaty has been appointed Head of US Commercial Operations.
- Load more news...
News
Our unique platform
Nevisense
The unique Nevisense platform utilizes advanced EIS- technology combined with AI to empower healthcare professionals by improving diagnostic accuracy, enabling disease monitoring, and facilitating early detection of skin cancer. The Nevisense procedure is non-invasive and provides clinicians with objective and actionable data, at point-of-care. It has been developed based on 20+ years of research from the Karolinska Institute and several years of clinical experience.
Lorem ipsum dolor
Lorem ipsum dolor
Integer venenatis sem in orci volutpat, eget placerat est mattis. Vivamus rhoncus leo sed nulla aliquam, id suscipit libero sagittis. Aenean vitae condimentum nisi, ac hendrerit libero.